Addex Therapeutics Ltd (ADXN) - Multiplikator Forward P/S
Swiss biotech Addex Therapeutics (ADXN) is protected by the humanitarian status of medicine, which eliminates political risks. Strict climate control during drug delivery ensures test safety, although it increases logistics costs. Revenues are based on the commercialization of neurotherapy for the treatment of Parkinson's disease. The forward price-to-sales ratio on this chart shows that the metric value is 56.40.
Rincian metrik keuangan lan pasar Addex (ADXN)
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi pasar:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Utang marang Ekuitas Addex Therapeutics|ADXN - Kewajiban jangka dawa marang ekuitas|Utang jangka cendhak marang modal Addex Therapeutics|ADXN - Utang kumulatif perusahaan|Utang marang nilai buku Addex|ADXN - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Addex Therapeutics|Rasio cepet addextherapeutics.com
- data bathi bisnis lan rasio investasi:
ADXN - Asil keuangan resik|Proyeksi bathi mangsa ngarep Addex Therapeutics|ADXN - Koefisien rega marang bathi|Rega marang bathi mangsa ngarep Addex Therapeutics, Ltd.|ADXN - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Addex|ADXN - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Addex Therapeutics|ADXN - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan addextherapeutics.com|ADXN - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Addex Therapeutics
- statistik dodolan lan pendapatan perusahaan:
Analisis wiwitan perusahaan:Addex Therapeutics Ltd (ADXN)
Holding unique CNS patents and maintaining barriers to entry for new players through extensive R&D, Addex Therapeutics (ADXN) operates under strict FDA oversight. The forward P/S multiple compares the company's current valuation with projected revenue to determine the premium paid for expected success. By analyzing this forward P/S multiple, an investor assesses whether market expectations regarding the business acquisition value are justified.
Pesaing Addex Therapeutics
Multiplikator Forward P/S BIIB (Biogen)|Rega forward marang dodolan NBIX|Regencell - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Axsome Corp|ACADIA Pharmaceuticals (ACAD) - Rasio rega marang prakiraan pendapatan|xenon-pharma.com - Rega forward marang dodolan|VKTX (Viking Therapeutics, Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S Supernus Pharmaceuticals, Inc.|Rasio rega marang prakiraan pendapatan Catalyst Pharmaceuticals Inc (CPRX)|DNLI: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S HRMY (Harmony Biosciences)|biohavenpharma.com (BHVN) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|AMLX: Multiplikator forward rega marang pendapatan|TRVI - Multiplikator Forward P/S|PRAX (Praxis Medicines) - Multiplikator forward rega marang pendapatan|AVXL: Rasio rega marang pendapatan sing dikarepake|CBLL (CeriBell, Inc.) - Multiplikator Forward P/S|Prothena Corporation (PRTA) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ALEC|Multiplikator forward rega marang pendapatan Annexon Biosciences ANNX|Rasio rega marang prakiraan pendapatan Omeros OMER|Rasio kapitalisasi marang dodolan sing dikarepake Neurogene Therapeutics (NGNE)|AC Immune - Multiplikator Forward P/S|VYGR - Multiplikator Forward P/S|NMRA: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan SCLX|Multiplikator forward rega marang pendapatan TVGN|Kapitalisasi marang prakiraan pendapatan ACOG (Alpha Cognition Corp)|Rasio rega marang prakiraan pendapatan Cognition Therapeutics (CGTX)|inhibikase.com - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Cassava Sciences SAVA|ASRT: Kapitalisasi marang prakiraan pendapatan|Coya - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Vistagen Therapeutics|OVID (ovidrx.com) - Multiplikator forward rega marang pendapatan|acumenpharm.com (ABOS) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan CervoMed|ATHE: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Clene Inc. (CLNN)|PEPG - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S JUNS (Jupiter Neurosciences Inc)|Multiplikator Forward P/S relmada.com RLMD|Annovis Bio - Multiplikator Forward P/S|GRCE (Grace Therapeutics, Inc.) - Kapitalisasi marang prakiraan pendapatan|AIFF: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan KLTO|NRSN (NeuroSense Therapeutics Ltd) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep revivapharma.com RVPH|Multiplikator forward rega marang pendapatan MTVA (MetaVia Inc)|NeurAxis Inc. - Kapitalisasi marang prakiraan pendapatan|Helius Medical Technologies - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan PASG|NEUP: Multiplikator forward rega marang pendapatan|minervaneurosciences.com - Rasio rega marang pendapatan sing dikarepake|ATHA: Multiplikator Forward P/S|Alzamend Neuro - Rega forward marang dodolan|CYCN (Cyclerion Therapeutics Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Protagenic PTIX|Rasio rega marang prakiraan pendapatan Pasithea Therapeutics (KTTA)|CRGT (cortigent.com) - Rega forward marang dodolan|Multiplikator Forward P/S ATXI (Avenue Therapeutics, Inc.)|Multiplikator Forward P/S Brainstorm Cell Therapeutics Inc. BCLI|CARA - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CHRO|ELYM: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Intra-Cellular Therapies, Inc. (ITCI)|Multiplikator forward rega marang pendapatan LBPH|Multiplikator Forward P/S Marinus Pharmaceuticals Inc|Multiplikator forward rega marang pendapatan NKGN (NKGen)|Rasio rega marang pendapatan sing dikarepake NRBO|Multiplikator Forward P/S SAGE (Sage Therapeutics, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake synaptogen.com (SNPX)|Trevena - Multiplikator Forward P/S|Vigil Neuroscience (VIGL) - Multiplikator forward rega marang pendapatan|Anew Medical (WENA) - Rasio rega marang prakiraan pendapatan|CERE - Rasio kapitalisasi marang dodolan sing dikarepake
